New biochemical markers in chronic heart failure

Area of Science:

• Cardiology
• Endocrinology
• Immunology

Background:

• Chronic heart failure (CHF) is associated with complex metabolic and inflammatory changes.
• Cachexia, a common complication of advanced CHF, involves muscle wasting and weight loss.
• Understanding the interplay of inflammatory cytokines and hormones in CHF is crucial for managing disease progression.

Purpose of the Study:

• To investigate plasma levels of tumour necrosis factor-alpha (TNF-alpha), leptin, and insulin in male patients with chronic heart failure.
• To examine the relationship between these biomarkers and body mass index (BMI) in different stages of heart failure.
• To assess the potential of these markers in determining CHF disease severity.

Main Methods:

• Plasma samples were collected from 80 male patients with chronic heart failure.
• Measurements included TNF-alpha, leptin, and insulin levels.
• Body Mass Index (BMI) was assessed, and patients were categorized by New York Heart Association (NYHA) functional classes.

Main Results:

• Significantly increased plasma levels of TNF-alpha, leptin, and insulin were observed in NYHA classes III and IV patients.
• A significant decrease in BMI was noted in advanced stages (III and IV) of heart failure.
• Positive correlations were found between TNF-alpha, leptin, and insulin; negative correlations existed between TNF-alpha/BMI and leptin/BMI in advanced CHF.

Conclusions:

• Cytokine and neuroendocrine activation are implicated in advanced-stage heart failure.
• This activation may contribute to the worsening of cachexia in CHF patients.
• Elevated TNF-alpha, leptin, and insulin can serve as potential biomarkers for CHF disease severity.